Primary care rebate schemes
Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, sometimes via third party companies, which offer retrospective financial rebates to Greater Manchester Integrated Care Board (GMICB) based on primary care prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or the GMMMG formulary.
All rebate applications are assessed against the GMMMG Ethical Framework for Primary Care Rebate schemes, which can be found at the bottom of this page along with the application form.
Please direct any enquiries regarding primary care rebate schemes to gmicb-old.medsman@nhs.net.
The primary care rebate schemes to which GMICB has signed up are as follows:
| Company | Product | Start date | End date |
|---|---|---|---|
| Chiesi Ltd | Fostair NEXTHaler dpi | 01/10/2022 | 30/09/2023 |
| Chiesi Ltd | Fostair pMDI | 01/10/2022 | 30/09/2023 |
| Chiesi Ltd | Clenil | 01/10/2022 | 30/09/2023 |
| Ethypharm | Xaggitin | 01/07/2022 | 30/11/2024 |
| Ethypharm | Espranor | 01/07/2022 | 30/11/2024 |
| Ethypharm | Pipexus | 01/07/2022 | 30/11/2024 |
| Ferring Pharmaceuticals Ltd | Firmagon | 01/07/2022 | 31/12/2024 |
| Luye Pharma | Fencino | 01/07/2022 | 30/11/2024 |
| Merck Serono Ltd | Glucophage SR | 01/07/2022 | 30/06/2024 |
| Takeda Ltd | Prostap | 01/07/2022 | 30/06/2024 |
| Viatris UK Healthcare Ltd | Sirdupla | 01/07/2022 | 31/03/2024 |
Expired rebate schemes
| Company | Product | Start date | End date |
|---|---|---|---|
| Sandoz Ltd | AirFluSal Forspiro | 01/07/2022 | 30/03/2023 |
| Document Title | Issue Date | Review Date | Status |
|---|---|---|---|
| Ethical Framework for Primary Care Rebate Applications | Sep 2022 | Version 9.1 | |
| Primary Care Rebate Scheme Application form | Sep 2022 | Version 5.1 |